FDA Investigator Art O Czabaniuk

Art O Czabaniuk has inspections in 2 countries as of 27 Oct 2023. Art O Czabaniuk has collaborated with a combinined 3063 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
45
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100002048
Country:
United States of America
Co-Investigator(s):
Abdul K Kamara, Adam J Wilson, Alan M Barker, Alanna Lmussawwir Bias, Alexandra A Carrico, Amy S Graf, Andrea F White, Anh M Lac, Anita Narula, PhD, Ann Raju Daniel, Anthony E Keller, RPh, Anthony F Lorenzo, Anthony R Petriella, Armando Morales, Aurora Miha Trifanov, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Smith, Bernard P Heidt, Brent M Dehaan, Brian P Henderickson, Brian P Hendrickson, Brian P Putz, Carmen M Faraianu, Caroline H Le, Carolyn J Oyster, Catherine V Quinlan, Cathie S Marshall, Charles M Spyr, Chelsea J Falkowski, Cheng H Yen, Cheryl A Clausen, Cheryl M Monroe, Christian D Lynch (CDL), Christine J Watts, Constantin Y Philopoulos, Courtney E Hillier, Crystal M Young Lewis, Cynthia L Aycock, Daniel J Brown, Daniel J Roberts, Daniel W Stoll, Darren S Morgan, David A Paterson, David J Gasparovich, David J Gsparovich, David L Wilson, David P Moorhead, Deanna L Lampley, Deborah M Trout, Dennis E Swartz, Dylan C Grippi, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric E Joneson, Gary Durbiel Goldner, George G Calafactor, Hartman, Hokenson, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James E Szelc, James R Evans, Jeannie M Melin, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, John N Woodall, Joneson, Joohi Castelvetere, Joseph A Piechocki, Joseph D Cooper, Joseph R Haynes, Joseph R Strelnik, Joseph T Madak, Judith A Jankowski, Kathryn A Cutajar, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Keith J Jasukaitis, Kelley L Clark, Kelli Wilkinson, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina Mezin, Kristina Nastovski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren M Lilly, PhD, LCDR Anastasia Mpiliafas Brown, Leslie A Paul, Linda S Jozefiak, Lindsey Brown, PhD, Lisa J Joseph, Lisa J Renick, Lisa M Thursam, Lisa P Oakes, LT Skip A Payne, LTJG Aaron B Otis, Margaret N Klug, Mark E Parmon, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Miah I Schneider, Michael Shanks, MS, Michele L Forster, PhD, Michelle L Jones, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Nancy A Bellamy, Neali H Lucas, Nicholas L Paulin, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Patrick B Cummings, Patsy J Domingo, Phenicia T Petty, Prabhu P Raju, Rasha Bamieh, Rebecca E Dombrowski, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Robert G Taylor, Robert M Barbosa, Robert P Whisenant, Roger A Hartman, Rohn R Robertson, Rose M Ashley, Ryan J Benedict, Salwa K Poole, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Sherri L Clark, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Sneha S Patel, Sonya M Lambkin, State Agency, Stuart W Russell, Susan M Jackson, Thomas A Peter, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Tyra L Vanleer, Vesa Vuniqi, Victoria A Murray, Wenzheng Zhang, William D Tingley, William G Nelson, William V Millar

Art O Czabaniuk's Documents

Publish Date Document Type Title
September, 2003 FDA 483 Response Applied Laboratories, Inc. - Form 483R, 2003-10-01
March, 2002 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2002-03-27
April, 2003 FDA 483 Ash Stevens LLC - Form 483, 2003-04-01
March, 2003 EIR Par Sterile Products LLC - EIR, 2003-03-03
September, 2003 EIR Applied Laboratories, Inc. - EIR, 2003-09-30
March, 2004 FDA 483 Arrow Chemical Products, Inc. - Form 483, 2004-03-12
October, 2005 FDA 483 Pfizer, Inc. - Form 483, 2005-10-05
April, 2003 EIR Ash Stevens LLC - EIR, 2003-04-01
October, 2005 EIR Pfizer, Inc. - EIR, 2005-10-05
November, 2003 FDA 483 W. R. Grace & Co.-Conn. - Form 483, 2003-11-13
February, 2008 EIR Burnette Foods, Inc - EIR, 2008-02-15
April, 2003 FDA 483 Response Ash Stevens LLC - Form 483R, 2003-04-14
September, 2002 FDA 483 Crandall Associate, Inc. - Form 483, 2002-09-30
September, 2002 FDA 483 Genesis Pharmaceutical, Inc. - Form 483, 2002-09-17
September, 2003 FDA 483 Applied Laboratories, Inc. - Form 483, 2003-09-30
May, 2004 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2004-05-18
May, 2004 FDA 483 Genesis Pharmaceutical, Inc. - Form 483, 2004-05-07
June, 2003 FDA 483 Liquipak Corporation - Form 483, 2003-06-23
June, 2002 FDA 483 Xela Pack, Inc. - Form 483, 2002-06-07
September, 2002 EIR Genesis Pharmaceutical, Inc. - EIR, 2002-09-17
December, 2003 FDA 483 Painexx Corporation - Form 483, 2003-12-23
March, 2011 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2011-03-25
March, 2003 FDA 483 Par Sterile Products LLC - Form 483, 2003-03-03
February, 2002 FDA 483 Baxter COMPASS - Form 483, 2002-02-07
September, 2002 FDA 483 Arrow Chemical Products, Inc. - Form 483, 2002-09-24
June, 2003 FDA 483 Mycol Balm Laboratories, Inc. - Form 483, 2003-06-23

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more